|
US7704944B2
(en)
|
1997-08-14 |
2010-04-27 |
Yeda Research And Development Company Ltd. |
Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
|
|
IL121860A0
(en)
|
1997-08-14 |
1998-02-22 |
Yeda Res & Dev |
Interleukin-18 binding proteins their preparation and use
|
|
US7220717B2
(en)
|
1997-08-14 |
2007-05-22 |
Yeda Research And Development Company Ltd. |
Interleukin-18 binding proteins, their preparation and use
|
|
FR2781483A1
(fr)
*
|
1998-07-21 |
2000-01-28 |
Hoechst Marion Roussel Inc |
Derives de thioazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicament et compositions pharmaceutiques les renfermant
|
|
US7015212B1
(en)
|
1999-05-12 |
2006-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thiazepine inhibitors of HIV-1 integrase
|
|
DK1355668T3
(da)
*
|
2001-01-29 |
2008-05-05 |
Serono Lab |
Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom
|
|
WO2002066063A1
(en)
*
|
2001-02-23 |
2002-08-29 |
Nippon Organon K.K. |
Remedies for metabolic bone diseases
|
|
US7001899B2
(en)
*
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
|
US20040151704A1
(en)
|
2002-06-28 |
2004-08-05 |
Xcyte Therapies, Inc. |
Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
|
|
CN1835769B
(zh)
*
|
2002-12-30 |
2011-06-29 |
比奥根艾迪克Ma公司 |
Kim-1拮抗剂及其在免疫系统调节中的应用
|
|
US20060128696A1
(en)
*
|
2004-05-15 |
2006-06-15 |
Annamaria Vezzani |
Treating seizures using ice inhibitors
|
|
JP2008520744A
(ja)
*
|
2004-11-19 |
2008-06-19 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
抗炎症性ピラゾロピリミジン
|
|
BRPI0608254A2
(pt)
|
2005-03-02 |
2009-12-08 |
Biogen Idec Inc |
anticorpos kim-1 para o tratamento de condições mediadas por th2
|
|
AU2007347115A1
(en)
|
2006-04-04 |
2008-10-23 |
The Regents Of The University Of California |
PI3 kinase antagonists
|
|
GB2467670B
(en)
*
|
2007-10-04 |
2012-08-01 |
Intellikine Inc |
Chemical entities and therapeutic uses thereof
|
|
DK2240451T3
(da)
*
|
2008-01-04 |
2017-11-20 |
Intellikine Llc |
Isoquinolinonderivater substitueret med en purin, der er anvendelig som pi3k-inhibitorer
|
|
US8193182B2
(en)
*
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
US8637542B2
(en)
*
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
BRPI0915231A2
(pt)
|
2008-07-08 |
2018-06-12 |
Intellikine Inc |
compostos inibidores de quinase e métodos de uso
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
CA2738429C
(en)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
CA2740885C
(en)
|
2008-10-16 |
2018-04-03 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
BRPI0914035A2
(pt)
|
2008-10-17 |
2015-11-03 |
Koninkl Philips Electronics Nv |
ventilador e método para ventilar um paciente usando um ventilador
|
|
US8476282B2
(en)
*
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
AU2011255218B2
(en)
|
2010-05-21 |
2015-03-12 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
CN103269586B
(zh)
|
2010-10-26 |
2015-07-15 |
普雷西迪奥制药公司 |
丙型肝炎病毒抑制剂
|
|
AU2011326427B2
(en)
|
2010-11-10 |
2016-01-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
PE20180318A1
(es)
|
2011-01-10 |
2018-02-09 |
Infinity Pharmaceuticals Inc |
Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
|
JP6130305B2
(ja)
|
2011-02-23 |
2017-05-17 |
インテリカイン， エルエルシー |
キナーゼ阻害剤の組み合わせおよびそれらの使用
|
|
WO2013012918A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
US9956260B1
(en)
|
2011-07-22 |
2018-05-01 |
The J. David Gladstone Institutes |
Treatment of HIV-1 infection and AIDS
|
|
AR091790A1
(es)
|
2011-08-29 |
2015-03-04 |
Infinity Pharmaceuticals Inc |
Derivados de isoquinolin-1-ona y sus usos
|
|
JP6342805B2
(ja)
|
2011-09-02 |
2018-06-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
置換ピラゾロ［３，４−ｄ］ピリミジンおよびその用途
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
KR20150061651A
(ko)
|
2012-09-26 |
2015-06-04 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Ire1의 조절
|
|
LT2914296T
(lt)
|
2012-11-01 |
2018-09-25 |
Infinity Pharmaceuticals, Inc. |
Vėžio gydymas, panaudojant p13 kinazės izoformos moduliatorius
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
WO2015051244A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103804367B
(zh)
*
|
2014-02-28 |
2016-09-14 |
天津药物研究院 |
苯并氮杂卓衍生物、其制备方法和用途
|
|
EP3119397B1
(en)
|
2014-03-19 |
2022-03-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
SG10201913880XA
(en)
|
2015-07-02 |
2020-03-30 |
Hoffmann La Roche |
Bicyclic lactams and methods of use thereof
|
|
CN114230571B
(zh)
|
2015-09-14 |
2025-07-08 |
无限药品股份有限公司 |
异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
|
|
CN118994191A
(zh)
|
2016-02-05 |
2024-11-22 |
戴纳立制药公司 |
受体相互作用蛋白激酶1的抑制剂
|
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
UA125216C2
(uk)
|
2016-06-24 |
2022-02-02 |
Інфініті Фармасьютікалз, Інк. |
Комбінована терапія
|
|
WO2018073193A1
(en)
|
2016-10-17 |
2018-04-26 |
F. Hoffmann-La Roche Ag |
Bicyclic pyridone lactams and methods of use thereof
|
|
HRP20220636T1
(hr)
|
2016-12-09 |
2022-07-22 |
Denali Therapeutics Inc. |
Spojevi korisni kao inhibitori ripk1
|
|
US11072607B2
(en)
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|
|
EP3781571B1
(en)
|
2018-04-20 |
2024-01-17 |
F. Hoffmann-La Roche AG |
N-[4-oxo-2,3-dihydro-pyrido[3,2-b][1,4]oxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
|
|
AU2023206890A1
(en)
|
2022-01-12 |
2024-08-22 |
Denali Therapeutics Inc. |
Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
|